Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
324 studies found for:    UVEITIS
Show Display Options
Rank Status Study
1 Recruiting Genetics of Uveitis
Conditions: Uveitis;   Infectious Uveitis
Intervention:
2 Active, not recruiting Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Conditions: Intermediate Uveitis;   Posterior Uveitis;   Pan-uveitis
Intervention: Drug: Tocilizumab
3 Active, not recruiting Optical Coherence Tomography (OCT) in Uveitis
Condition: Uveitis
Intervention:
4 Not yet recruiting Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Condition: Uveitis
Intervention: Drug: Acthar
5 Completed Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
Condition: Uveitis
Interventions: Other: Free strategy;   Other: Standardized strategy
6 Active, not recruiting Clinical Outcome in Uveitis
Condition: Uveitis
Intervention:
7 Recruiting Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
Condition: Uveitis
Intervention: Other: Blood sampling
8 Completed
Has Results
Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis
Condition: Uveitis
Interventions: Drug: B27PD;   Drug: Placebo
9 Completed Infectious Causes of Uveitis
Condition: Uveitis
Intervention:
10 Completed
Has Results
Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed
11 Completed Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
Condition: Uveitis
Intervention: Drug: everolimus
12 Completed
Has Results
Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis
Condition: Chronic Uveitis
Intervention: Drug: infliximab
13 Recruiting Study of the Effectiveness of Ozurdex for the Control of Uveitis
Conditions: Uveitis, Intermediate;   Uveitis, Posterior
Intervention: Drug: Dexamethasone pellet
14 Terminated The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Condition: Non-infectious Uveitis
Interventions: Drug: Basiliximab;   Drug: Placebo
15 Active, not recruiting A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab
16 Recruiting Childhood Uveitis Initial Management and One-year Outcomes
Condition: Uveitis.
Intervention: Other: Surveillance card
17 Unknown  Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
Condition: Uveitis
Intervention: Drug: Myfortic
18 Unknown  Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
Condition: Uveitis
Intervention: Drug: Adalimumab
19 Withdrawn Ustekinumab for Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
20 Completed Quality of Life in Juvenile Patients With Uveitis
Condition: Uveitis
Intervention: Other: Filling in a psychometric questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.